Free Trial
NASDAQ:BDRX

Biodexa Pharmaceuticals (BDRX) Stock Price, News & Analysis

Biodexa Pharmaceuticals logo
$0.90 +0.02 (+2.55%)
As of 11:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Biodexa Pharmaceuticals Stock (NASDAQ:BDRX)

Key Stats

Today's Range
$0.89
$0.93
50-Day Range
$0.80
$1.39
52-Week Range
$0.78
$19.75
Volume
40,851 shs
Average Volume
2.00 million shs
Market Capitalization
$33.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

BDRX Stock News Headlines

ADR Ratio Change
Genesis 14:13-17 [HIDDEN MEANING?]
A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.
Results of Annual General Meeting
See More Headlines

BDRX Stock Analysis - Frequently Asked Questions

Biodexa Pharmaceuticals' stock was trading at $4.05 at the beginning of 2025. Since then, BDRX shares have decreased by 77.5% and is now trading at $0.9110.

Biodexa Pharmaceuticals PLC Unsponsored ADR (NASDAQ:BDRX) announced its earnings results on Thursday, September, 10th. The company reported ($1,600.00) earnings per share for the quarter.

Biodexa Pharmaceuticals's stock reverse split before market open on Friday, October 4th 2024.The 1-25 reverse split was announced on Thursday, September 19th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Shares of BDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biodexa Pharmaceuticals investors own include SoundHound AI (SOUN), Dyne Therapeutics (DYN), NVIDIA (NVDA), Viking Therapeutics (VKTX), TRACON Pharmaceuticals (TCON), ASE Technology (ASX) and BigBear.ai (BBAI).

Company Calendar

Last Earnings
9/10/2020
Today
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BDRX
Previous Symbol
LON:MTPH
CIK
1643918
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
1.75
Quick Ratio
1.75

Sales & Book Value

Annual Sales
$470 thousand
Price / Sales
68.61
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.29 per share
Price / Book
3.04

Miscellaneous

Outstanding Shares
36,540,000
Free Float
36,420,000
Market Cap
$32.25 million
Optionable
Not Optionable
Beta
1.17
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:BDRX) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners